Dr. Richard Marlink. (File photo)
Dr. Richard Marlink, the director of the Rutgers Global Health Institute, will be featured on a webinar on all things COVID-19 (including the latest Johnson & Johnson vaccine) and population health.
The webinar is presented and hosted by James Barrood, a well-known figure in the New Jersey tech community.
Marlink, the inaugural Henry Rutgers Professor of Global Health, came to Rutgers University in the summer of 2017 after two decades at the Harvard T.H. Chan School of Public Health, where he served as the executive director of the Harvard AIDS Institute.
The webinar will discuss a number of issues, including:
PrePex promises less pain and less time We believe that the PrePex is the only circumcision method that will allow us to meet the goal of [circumcising] over 1.5 million men in two years, Vincent Mutabazi, lead investigator in the Rwandan PrePex studies. Several campaigns and numerous training[s] of new PrePex healthcare providers have taken place. Some 5,000 men were circumcised outside of [the] clinical environment in Rwanda since [February 2012]. In the upcoming months, more than 200,0000 procedures are expected.
“Safer, faster and reduces discomfort”
In Botswana, the health ministry, in collaboration with the US Embassy, the African Comprehensive HIV/AIDS Partnership (ACHAP) and Jhpiego, an affiliate of the US s Johns Hopkins University, are carrying out pilot research at Nkoyaphiri Clinic, Mogoditshane and Block 8 Clinic in the capital, Gaborone. The study targets 1,000 HIV-negative men aged 18 to 49 to evaluate the effectiveness and safety of PrePex; so far 330 adul